retatrutide phase 2 trial obesity nejm 2023 What is Medscape | The investigational triple

Our protocol signals the body to maintain these areas

One mechanism most guides ignore: Retatrutide's dual receptor activity means it stimulates both insulin secretion (via GIP) and delays gastric emptying (via GLP-1) simultaneously

Open 8:e2457349

However, patients should not self-treat severe or persistent constipation without medical advice, especially if they develop pain, bloating, vomiting, inability to pass stool or gas, or rectal bleeding

As with any medication it is important to be aware of risks of side effects

Medications with narrow therapeutic windows (like warfarin, levothyroxine, or certain diabetes medications) may need dose adjustments when combined with semaglutide